Apogee's APG777 showed a 71% drop in eczema severity and strong itch relief in a Phase 2 trial for atopic dermatitis. Part B ...

The XDI report highlights climate risks in Indian data centers, urging structural adaptations for long-term viability and ...

The global gold market now stands at a critical juncture, with both fundamentals and technical indicators suggesting a ...

A new Delphi consensus led by the National Psoriasis Foundation proposes a standardized definition of on-treatment remission ...

Promising Psoriasis Pipeline Therapies such as Hypericin, EDP1815, Cetaphil, AX-158, HAT1 topical solution, Calcipotriol, ARQ ...

The mechanism involves atmospheric waves that bounce between the upper atmosphere and ground level, amplifying weather patterns and making them more extreme. Scientists call this “stratospheric wave ...

Given that China's pro-growth policies are helping the domestic economy maintain its growth momentum in recent months, ...

It took the worst bond market in history to make investing in a 60/40 more painful during a market crash than holding all ...

LEO Pharma has reported outcomes from the 16-week interim analysis of the Phase IIIb ADHAND trial of tralokinumab for hand atopic dermatitis (AD).

Apogee Therapeutics, Inc. (NASDAQ:APGE) is one of the 10 Stocks Crash Hard Alongside Wall Street. Apogee Therapeutics fell by ...

Ripple concludes blockchain-based drought insurance pilot in Kenya, insuring 517 pastoralists using RLUSD stablecoin.